ArticleRedox biology2026

Targeted degradation of hepatic KEAP1 mitigates drug-induced liver injury via dual boosting NRF2 and PGAM5 signaling.

Yanyan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.